Edgemond James's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jun 9, 2026
- Accession no.
- 0001636178-26-000025
- Filed
- Jun 9, 2026
- Trade date
- Jun 8, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.48M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edgemond JamesCIK 0001636178 | Officer (CFO AND TREASURER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Common Stock | MOption exerciseAcquired | +10,000 | $117.76 | +$1,177,600 | 28,876 | Direct | |
| Jun 8, 2026 | Common Stock | SSaleDisposed | −1,565 | $544.93F2 | −$852,815.45 | 27,311 | Direct | |
| Jun 8, 2026 | Common Stock | SSaleDisposed | −1,989 | $546.13F3 | −$1,086,252.57 | 25,322 | Direct | |
| Jun 8, 2026 | Common Stock | SSaleDisposed | −1,888 | $547.03F4 | −$1,032,792.64 | 23,434 | Direct | |
| Jun 8, 2026 | Common Stock | SSaleDisposed | −2,158 | $547.91F5 | −$1,182,389.78 | 21,276 | Direct | |
| Jun 8, 2026 | Common Stock | SSaleDisposed | −425 | $549.38F6 | −$233,486.5 | 20,851 | Direct | |
| Jun 8, 2026 | Common Stock | SSaleDisposed | −1,285 | $550.09F7 | −$706,865.65 | 19,566 | Direct | |
| Jun 8, 2026 | Common Stock | SSaleDisposed | −610 | $551.28F8 | −$336,280.8 | 18,956 | Direct | |
| Jun 8, 2026 | Common Stock | SSaleDisposed | −80 | $551.76F9 | −$44,140.8 | 18,876 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 20,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $544.41 to $545.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $545.47 to $546.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $546.51 to $547.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $547.52 to $548.485. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $548.59 to $549.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $549.59 to $550.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $550.63 to $551.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $551.74 to $551.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.